Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein.
暂无分享,去创建一个
O. Ramilo | W. Gruber | P. Sánchez | H. Jafri | R. Malley | D. Ambrosino | J. Devincenzo | H. Meissner | P. Dennehy | L. Vernacchio | S. Buckingham | D. Carlin | J. Balsley | J. DeVincenzo | J. Devincenzo
[1] R. Ariagno,et al. Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study Group. , 1998, The Pediatric infectious disease journal.
[2] W. Gruber,et al. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children. , 1997, Pediatrics.
[3] D. Pfarr,et al. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. , 1997, The Journal of infectious diseases.
[4] W. Dankner. Reduction of Respiratory Syncytial Virus Hospitalization Among Premature Infants and Infants with Bronchopulmonary Dysplasia Using Respiratory Syncytial Virus Immune Globulin Prophylaxis , 1997, Pediatrics.
[5] W. Gruber,et al. Respiratory Syncytial Virus (RSV) Immune Globulin Intravenous Therapy for RSV Lower Respiratory Tract Infection in Infants and Young Children at High Risk for Severe RSV Infections , 1997 .
[6] E. Wang,et al. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database. , 1997, Pediatrics.
[7] E. Wang,et al. Ribavirin for respiratory syncytial virus lower respiratory tract infection. A systematic overview. , 1996, Archives of pediatrics & adolescent medicine.
[8] R. Soiffer,et al. Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation. , 1996, Bone marrow transplantation.
[9] S. Ohmit,et al. Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group. , 1996, The Journal of pediatrics.
[10] P. Openshaw. Immunity and immunopathology to respiratory syncytial virus. The mouse model. , 1995, American journal of respiratory and critical care medicine.
[11] A. Milner,et al. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. , 1994, Archives of disease in childhood.
[12] E. Walsh,et al. Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin. , 1994, The Journal of infectious diseases.
[13] C. Hall,et al. Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children , 1993 .
[14] B. Graham,et al. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. , 1993, Journal of immunology.
[15] B. Osborne,et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. , 1992, The Journal of infectious diseases.
[16] C. Cunningham,et al. Rehospitalization for respiratory illness in infants of less than 32 weeks' gestation. , 1991, Pediatrics.
[17] R. Garofalo,et al. Concentrations of LTB4, LTC4, LTD4 and LTE4 in bronchiolitis due to respiratory syncytial virus , 1991 .
[18] H. Balfour,et al. Respiratory syncytial virus infection in immunocompromised adults. , 1988, Annals of internal medicine.
[19] K. Gutierrez,et al. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. , 1988, Pediatrics.
[20] G. Prince,et al. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children , 1987, Antimicrobial Agents and Chemotherapy.
[21] C. Hall,et al. Respiratory syncytial viral infection in infants with congenital heart disease. , 1982, The New England journal of medicine.
[22] J. Englund,et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. , 1995, Bone marrow transplantation.
[23] R. Garofalo,et al. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. , 1992, The Journal of pediatrics.